Function of gastro-intestinal mucin-derived acidic oligosaccharaides recognized by anti-mucin monoclonal antibodies
抗粘蛋白单克隆抗体识别的胃肠粘蛋白衍生酸性寡糖的功能
基本信息
- 批准号:16590629
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We developed a monoclonal antibody, designated PGM34, by immunizing a mouse with purified pig gastric mucin. PGM34 recognized the carbohydrate portion of the mucins. Oligosaccharide-alditols obtained from the pig gastric mucin were fractionated by successive gel-filtration, ion-exchange, and normal phase high-performance liquid chromatography, and tested for the reactivity with PGM34. Two purified oligosaccharide-alditols reacting with PGM34 were obtained and their structures were determined by nuclear magnetic resonance spectroscopy as Fucα1-2Galβ1-4GlcNAc(6SO_3H)β1-6(Fucα1-2Galβ1-3)GalNAc-ol and Fucα1-2-Galβ1-4GlcNAc (6SO_3H) β1-6 (Galβ1-3)Gal-NAc-ol. None of the defucosylated or desulfated form of these oligosaccharides reacted with PGM34. Thus, the epitope of PGM34 was determined as the Fucα1-2Galβ1-4GlcNAc (6SO_3H)β-sequence. Immunohistochemical observations of rat gastrointestinal tracts showed that PGM34 stained the surface mucous cells close to the generative cell zone in the g … More astric fundus and the goblet cells in the small intestine, but only slightly stained the antral mucous cells in the stomach. These data, taken together, showed that PGM34 is a very useful tool to reveal the role of mucins having characteristic sulfated oligosaccharides.To investigate the antineoplastic chemotherapy-induced small intestinal injury, 5-fluorouracil(5-FU) was orally administered to rats for 5 days. The 5-FU treatment caused a significant decrease in the number of mucus cells in the small intestine observed by an immunohistochemical method using PGM34. This reduction of mucus cells was significantly inhibited by the co-administration of lafutidine, a novel H2-blocker, but not by cimetidine, an H2-blocker of the first generation. The mucin content in the small intestine significantly decreased in the 5-FU treated group. This reduction was significantly recovered by the co-administration of lafutidine. These results support the efficacy of lafutidine toward 5-FU-induced mucositis in rat small intestine. Less
我们用纯化的猪胃粘蛋白免疫小鼠,研制了一种单克隆抗体,命名为PGM 34。PGM 34识别粘蛋白的碳水化合物部分。从猪胃粘蛋白中获得的寡糖-糖醇通过连续的凝胶过滤、离子交换和正相高效液相色谱法分级分离,并测试与PGM 34的反应性。从PGM 34中分离得到两个纯化的寡糖糖醇,经核磁共振谱鉴定其结构为Fucα1-2Galβ1-4GlcNAc(6SO 3 H)β1-6(Fucα1-2Galβ1-3)GalNAc-ol和Fucα1-2-Galβ1-4GlcNAc(6SO 3 H)β1-6(Galβ1-3)Gal-NAc-ol。这些低聚糖的去岩藻糖基化或脱岩藻糖基化形式均不与PGM 34反应。因此,PGM 34的表位被确定为Fucα1-2Galβ1-4GlcNAc(6SO_3H)β-序列。大鼠胃肠道的免疫组化观察显示,PGM 34染色于胃肠道内靠近生殖细胞区的表面粘液细胞, ...更多信息 胃底和小肠杯状细胞染色,而胃窦粘液细胞染色较浅。这些数据,放在一起,表明,PGM 34是一个非常有用的工具,以揭示具有特征性硫酸化oligosaccharides的粘蛋白的作用。通过使用PGM 34的免疫组织化学方法观察到,5-FU处理导致小肠中粘液细胞数量显著减少。这种粘液细胞的减少被拉呋替丁(一种新的H2受体阻滞剂)的共同给药显著抑制,但不是由西咪替丁(第一代H2受体阻滞剂)抑制。5-FU治疗组小肠粘蛋白含量显著降低。这种降低在与拉呋替丁联合给药后显著恢复。这些结果支持拉呋替丁对5-FU诱导的大鼠小肠粘膜炎的疗效。少
项目成果
期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of tea catechin administration on the change in gastro-intesttinal mucus in rats
茶儿茶素给药对大鼠胃肠粘液变化的影响
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Ito Y;Ichikawa T;Ikezawa T;Saegusa Y;Tsubokawa D;Kuruhara M;Goso Y;Okayasu I;Ishihara K.
- 通讯作者:Ishihara K.
Characterization of oligosaccharide epitope recognized by anti-mucin monoclonal antibody, RGM21, using neoglycoconjugate technology
使用新糖缀合物技术表征抗粘蛋白单克隆抗体 RGM21 识别的寡糖表位
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Goso Y;Endo M;Kuruhara M;Ishihara K.
- 通讯作者:Ishihara K.
Effect of Lafutidine, an H2-blocker, in the rat gastric mucosa regenetating from acetic acid-induced ulcer
H2阻滞剂拉呋替丁对醋酸溃疡大鼠胃粘膜再生的影响
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Ikezawa T;Saegusa Y;Ichikawa T;Goso Y;Kuruhara M;Saigenji K;Okayasu I;Ishihara K.
- 通讯作者:Ishihara K.
Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa
- DOI:10.1111/j.1440-1746.2006.04721.x
- 发表时间:2007-11-01
- 期刊:
- 影响因子:4.1
- 作者:Ichikawa, Takafumi;Ota, Hiroyoshi;Ishihara, Kazuhiko
- 通讯作者:Ishihara, Kazuhiko
Protective effects of the whisky congeners on ethanol-induced gastric mucosal damage
- DOI:10.1111/j.1530-0277.2006.00319.x
- 发表时间:2007-03-01
- 期刊:
- 影响因子:3.2
- 作者:Goso, Yukinobu;Ueno, Masaki;Ishihara, Kazuhiko
- 通讯作者:Ishihara, Kazuhiko
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHIHARA Kazuhiko其他文献
Synthesis of Thereto-Responsive Hydrogel Cross-Linked by Gold Nano Collaid
金纳米胶交联响应性水凝胶的合成
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
GOTO Fumi;YUSA Shin-ichi;MORISHIMA Yotaro;ISHIHARA Kazuhiko - 通讯作者:
ISHIHARA Kazuhiko
ISHIHARA Kazuhiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHIHARA Kazuhiko', 18)}}的其他基金
Preparation of cell-based electron-generator
细胞电子发生器的制备
- 批准号:
22650107 - 财政年份:2010
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Preparation of biocompatible polymer nanoparticles as cell-function analysis biodevices
作为细胞功能分析生物器件的生物相容性聚合物纳米颗粒的制备
- 批准号:
21300176 - 财政年份:2009
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on a formulation of housing policy vision by character of area and renewal policy in suburb from view point of shrinking city
收缩城市视角下分区特征住房政策愿景制定及郊区更新政策研究
- 批准号:
18600009 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DETERMINATION OF MECHANISM FOR MOLECULAR ADHESION TO SOFT TISSUES AND MATERALS PREPARATION
软组织分子粘附机制的测定及材料制备
- 批准号:
17300144 - 财政年份:2005
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structure Control and Functions of Biocompatible Polymer Alloy as Biomaterials
生物相容性聚合物合金作为生物材料的结构控制和功能
- 批准号:
13480288 - 财政年份:2001
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A systematic development of monoclonal antibodies against mucins of digestive tract and their application to pathophysiological studies
抗消化道粘蛋白单克隆抗体的系统开发及其在病理生理学研究中的应用
- 批准号:
12670514 - 财政年份:2000
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PREPARATION OF NOVEL HEMOCOMPATIBLE HOLLOW FIBER MEMBRANE AND DEVICE FOR SAFETY BLOOD PURIFICATION HOME
新型血液相容性中空纤维膜及安全血液净化装置的制备
- 批准号:
10558131 - 财政年份:1998
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
PREPARATION OF NOVEL BIOMEDICAL POLYMERS HAUING BIOMEMBRANE-LIKE SURFACE AND RECOGNITION OF THEIR NON THROMBOGENIC
具有类生物膜表面的新型生物医用聚合物的制备及其非血栓形成的识别
- 批准号:
09480250 - 财政年份:1997
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Mucus secretion studies using anti-gastric mucin monoclonal antibodies
使用抗胃粘蛋白单克隆抗体进行粘液分泌研究
- 批准号:
07670612 - 财政年份:1995
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preparation of Novel Biocompatible polymeric Additives and Modification of Biomedical Materials Using the Additives
新型生物相容性高分子添加剂的制备及其对生物医用材料的改性
- 批准号:
07680934 - 财政年份:1995
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
Mucin蛋白在泌丝动物家蚕和蜘蛛中的功能研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
维生素D受体通过抑制Mucin-1/β1-integrin信号通路调节肠道衰老的相关机制研究
- 批准号:MS25H030029
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
肠粘蛋白mucin介导的中肠黏膜屏障在蜜蜂感染囊状幼虫病毒
( SBV )差异性的作用研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
黏蛋白1(Mucin1)在脓毒症ALI/ARDS铁死亡发生过程中的作用和机制研究
- 批准号:82300106
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于mRNA m5C修饰对PORCN表达水平与核质穿梭的调控探究新型PC/Mucin 涂层促进骨再生的作用机制
- 批准号:82302698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Mucin-16/Siglec-10信号调控肿瘤相关巨噬细胞重编程促进胃癌免疫逃逸的作用和机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
Mucin1调节角膜上皮细胞间连接在糖尿病角膜上皮修复中的作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
补气通络胶囊通过外泌体上调Mucin 1及其在骨质疏松性骨折修复中的作用和机制
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
金黄色葡萄球菌调节mucin表达影响鼻黏膜黏液屏障在慢性鼻窦炎发病中的作用及其机制研究
- 批准号:81970857
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
Mucin-1/Wnt/β-catenin通路在高血压肾脏纤维化中的调控作用及机制研究
- 批准号:81970353
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Mucin‐中分子薬物間相互作用の分子機構解明
阐明粘蛋白-介质分子药物相互作用的分子机制
- 批准号:
24K09897 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
幽門腺型粘液の糖鎖に注目したがん抑制機構の解明と、早期がん診断への応用
阐明幽门腺型粘液中糖链的抑癌机制及其在早期癌症诊断中的应用
- 批准号:
23K06430 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Hybrid Materials of Mucin-Synthetic Polymer for Application to Intestinal Bacteria Culture
用于肠道细菌培养的粘蛋白合成聚合物杂化材料的开发
- 批准号:
23K04863 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for human-microbiome symbiosis mediated by the sulfated mucin glycan-terminal structures
阐明硫酸化粘蛋白聚糖末端结构介导的人类微生物组共生机制
- 批准号:
23K05009 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Unraveling the adaptive evolution of gut microbes through a novel metabolic pathway of a saccharide composing of host derived-mucin glycan
通过由宿主衍生的粘蛋白聚糖组成的糖类的新代谢途径揭示肠道微生物的适应性进化
- 批准号:
23KJ1259 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Core - Biomarker Developmental Laboratory (BDL)
核心 - 生物标志物发育实验室 (BDL)
- 批准号:
10701482 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
The role of a bifunctional mucinase in modulating personalized gut microbiota-Vibrio cholerae interactions during infection
双功能粘蛋白酶在感染期间调节个性化肠道微生物群-霍乱弧菌相互作用中的作用
- 批准号:
10749595 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
The regulation of airway mucin secretion by extra cellular matrix
细胞外基质对气道粘蛋白分泌的调节
- 批准号:
23K05768 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment
以乳腺癌为重点的生物标志物表征中心在 CLIA 环境中采用靶向质谱分析
- 批准号:
10701480 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Proteasome Inhibitor-Loaded Antibody Drug Conjugates with High Drug Loading For Targeted Treatment of Triple Negative Breast Cancers
负载蛋白酶体抑制剂的高载药量抗体药物偶联物用于三阴性乳腺癌的靶向治疗
- 批准号:
10822628 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:














{{item.name}}会员




